Timolol - Glaucoma / ocular hypertension
You are here : Home > Formulary Search > Timolol - Glaucoma / ocular hypertension
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Blue
Formulations :
- Eye drops
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
0.25% and 0.5% eye drops. Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
Status 2
Blue
Formulations :
- Eye gel
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
0.25% and 0.5% gel-forming solution (Timoptol-LA)
Initiation by specialist team before transfer of prescribing to primary care.
Status 3
Blue
Formulations :
- Eye drops (preservative free
- unit dose)
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
0.1% (1mg/g) preservative free eye gel. Once daily use.
Initiation by specialist team before transfer of prescribing to primary care.
Documentation
Miscellaneous
PAD Profile
ChemicalSubstance :
Timolol
Indication :
Glaucoma / ocular hypertension
Group Name :
Keywords :
Intra-ocular pressure
Brand Names Include :
Tiopex, Timoptol-LA, Eysano, Timoptol,
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
3
Other Drugs
Below are listed other drugs that are used to treat Glaucoma / ocular hypertension.
- Acetazolamide
- Apraclonidine
- Betaxolol
- Bimatoprost
- Bimatoprost with timolol
- Brimonidine tartrate
- Brimonidine with timolol
- Brinzolamide
- Brinzolamide with brimonidine
- Brinzolamide with timolol
- Dorzolamide
- Dorzolamide with timolol
- Latanoprost
- Latanoprost with netarsudil
- Latanoprost with timolol
- Levobunolol hydrochloride
- Pilocarpine hydrochloride
- Tafluprost
- Travoprost
- Travoprost with timolol
Committee Recommendations (2)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
The PCN recommends the prescribing of timolol maleate 1mg/g preservative free eye gel (Tiopex) as an alternative treatment option*, for the reduction of elevated intraocular pressure in patients with ocular hypertension or glaucoma where a preservative free preparation is indicated. Tiopex will be considered Blue (no information sheet) on the traffic light system. *Once daily formulation which may be a more cost effective treatment option for some patients as an alternative to timolol preservative free single dose vials.